Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Feb 5;14(3):1004.
doi: 10.3390/jcm14031004.

Malignant Pleural Mesothelioma: A 2025 Update

Giuseppe Cardillo  1   2 , David Waller  3 , Sara Tenconi  4 , Vincenzo Di Noia  5 , Sara Ricciardi  1
Affiliations
Editorial

Malignant Pleural Mesothelioma: A 2025 Update

Giuseppe Cardillo et al. J Clin Med. .

Abstract

The incidence of pleural mesothelioma (PM) is slightly increasing, with 2417 new cases/year worldwide [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Bou-Samra P., Chang A., Azari F., Kennedy G., Segil A., Guo E., Marmarelis M., Langer C., Singhal S. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database. Cancer Med. 2023;12:12208–12220. doi: 10.1002/cam4.5915. - DOI - PMC - PubMed
    1. WHO . Classification of Tumours Editorial Board WHO Classification of Tumours: Thoracic Tumours International Agency for Research on Cancer. WHO; Lyon, France: 2021.
    1. Nowak A.K., Giroux D.J., Eisele M., Nishimura K., Rusch V.W., Rosenthal A., Bille A., Gill R.R., Kindler H.L., Pass H.I., et al. The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Proposal for Revision of the TNM Stage Groupings in the Forthcoming (Ninth) Edition of the TNM Classification for Pleural Mesothelioma. J. Thorac. Oncol. 2024;19:1339–1351. doi: 10.1016/j.jtho.2024.05.002. - DOI - PubMed
    1. Rimner A., Zauderer M.G., Gomez D.R. Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma. J. Clin. Oncol. 2016;34:2761–2768. doi: 10.1200/JCO.2016.67.2675. - DOI - PMC - PubMed
    1. Van Schil P.E., Baas P., Gaafar R., Maat A.P., Van de Pol M., Hasan B., Klomp H.M., Abdelrahman A.M., Welch J., van Meerbeeck J.P. Trimodality therapy for malignant pleural mesothelioma: Results from an EORTC phase II multicentre trial. Eur. Respir. J. 2010;36:1362–1369. doi: 10.1183/09031936.00039510. - DOI - PubMed

Publication types

LinkOut - more resources